LiverMultiScan™ is an MRI-based technology that can non-invasively characterise liver tissue and aid a clinician in diagnosing liver disorders.

 

This technology is ideal for characterising tissue as it is sensitive to subtle differences in tissue composition, can sample the entire liver quickly, is safe, reproducible, and yields objective measurements which can significantly contribute to patient care.

 

LiverMultiScan™ has both FDA 510(k) clearance and CE-marking, meaning it is available for clinical use in both the US and Europe. 

ClinicalTrials.gov Identifier: NCT03213314

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon